GlassScriptPhysician profile
Monica Andres
NPI 1427001692
$15,061.08
in general payments reported to CMS, 2019-2025
6 companies · $15K in 2025
The $15K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.30 · 2020: $104 · 2021: $29.80 · 2022: $47.65 · 2023: $13.48 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $15K · Food and Beverage: $30.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $14,800.00 |
| Food and Beverage | $30.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $14,800.00 | 2025 | |
| Smith+Nephew, INC. | $85.97 | 2019-2020 | |
| Kci USA, INC. | $83.10 | 2020-2022 | |
| Paratek Pharmaceuticals, INC. | $49.51 | 2020-2023 | Nuzyra |
| Stimwave Technologies Incorporated | $25.18 | 2022 | |
| Ibsa Pharma INC. | $17.32 | 2025 | Flector, Licart, Tirosint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Andres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.